Jazz Pharmaceuticals (JAZZ) Capital Expenditures (QoQ) (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) Capital Expenditures (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Jazz Pharmaceuticals | 15.78 Bn | 13.93 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 109.66% |
| Dec 31, 2025 | -193.24% |
| Sep 30, 2025 | 106,789.15% |
| Dec 31, 2024 | 23.16% |
| Sep 30, 2024 | 8.91% |
| Jun 30, 2024 | 142.18% |
| Mar 31, 2024 | 129.51% |
| Dec 31, 2023 | -1,555.88% |
| Sep 30, 2023 | -89.52% |
| Jun 30, 2023 | 137.73% |
| Mar 31, 2023 | -12.54% |
| Dec 31, 2022 | -77.40% |
| Sep 30, 2022 | 1,378.52% |
| Jun 30, 2022 | 233.61% |
| Mar 31, 2022 | 94.71% |
| Dec 31, 2021 | -205.66% |
| Sep 30, 2021 | 5,203.33% |
| Jun 30, 2021 | 310.19% |
| Mar 31, 2021 | -100.54% |
| Dec 31, 2020 | 234.87% |